https://www.selleckchem.com/products/OSI-906.html
Deferoxamine (DFO) is FDA approved to treat iron overload, either acute or chronic. The definition of iron overload is serial ferritin levels above 800 to 3000 ng/mL . The FDA has not approved DFO as first-line therapy for hereditary hemochromatosis unless there is a contraindication to phlebotomy. Clinicians can also use DFO is also used as an off-label treatment for aluminum toxicity in chronic kidney disease (CKD) patients.Diclofenac is an FDA approved drug used in the treatment and management of acute and chronic pain associated wit
Like
Comment
Share
